APA (7th ed.) Citation

E, E., M, S., C, R., V, M., E, S., & M, M. (2021). Response to Letter to the Editor: "High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?". Endocrine, 71(1), 263. https://doi.org/10.1007/s12020-020-02584-y

Chicago Style (17th ed.) Citation

E, Espinosa-Cárdenas, Sánchez-García M, Ramírez-Rentería C, Mendoza-Zubieta V, Sosa-Eroza E, and Mercado M. "Response to Letter to the Editor: "High Biochemical Recurrence Rate After Withdrawal of Cabergoline in Prolactinomas: Is It Necessary to Restart Treatment?"." Endocrine 71, no. 1 (2021): 263. https://doi.org/10.1007/s12020-020-02584-y.

MLA (9th ed.) Citation

E, Espinosa-Cárdenas, et al. "Response to Letter to the Editor: "High Biochemical Recurrence Rate After Withdrawal of Cabergoline in Prolactinomas: Is It Necessary to Restart Treatment?"." Endocrine, vol. 71, no. 1, 2021, p. 263, https://doi.org/10.1007/s12020-020-02584-y.